# BioQ > BioQ is a bio search engine and AI agent with all public bio data already collected. Ask a question in the web app, over the REST API, or from Claude, ChatGPT or Cursor through MCP, and get an answer with its sources. - Data: 97 datasets from 42 providers (proteins, metagenomes, structures, chemistry, variants, interactions, cancer models, genomes), listed in the catalog. - REST API: base URL `https://bioq.bio/api/v1`; send `Authorization: Bearer bq_…` with an API key. Answers are JSON, and every answer that reads data says where it was read from. - MCP: remote read-only server at `https://bioq.bio/mcp` (Streamable HTTP; sign in with OAuth or send an API key). Each tool result names its source and a bioq.bio link to cite. - Access: anyone with a verified email can use the Free plan (monthly limits per account); companies get paid plans by approval (daily limits per person). A call from an account without access answers 403 (`subscription_required`, `payment_required`, `suspended`, `contract_expired` or `contract_not_started`) and is not counted. A call over a quota answers 429 (`quota_exceeded`, or `free_capacity` when the Free plan’s shared daily capacity is used up). Only `GET https://bioq.bio/api/v1/status` works without a key. - Reading answers: `miss` or `absent` means searched and not found. `unavailable`, `timeout` and `not_applicable` mean nothing was searched, so never report them as absence. Lists can be truncated; say so. - BioQ is operated by AI3 Discovery (https://ai3discovery.com). Company: AI3 Inc. ## Documentation - [API reference](https://bioq.bio/docs.md): Every BioQ answer is available as JSON over HTTPS. Use the same endpoints as the app, from any language. - [Claude, ChatGPT, Cursor (MCP)](https://bioq.bio/mcp.md): Connect BioQ to Claude, ChatGPT or Cursor as a remote MCP server: URL, sign-in, setup steps per client, and the list of tools. - [OpenAPI spec](https://bioq.bio/static/openapi.json): OpenAPI 3.1 description of every public endpoint (JSON, English). - [llms-full.txt](https://bioq.bio/llms-full.txt): Everything in one Markdown file: product, access, limits and errors, every endpoint, MCP tools, dataset catalog and pricing. ## Data and engine - [Catalog](https://bioq.bio/catalog.md): 97 datasets from 42 providers, already downloaded, verified, indexed and cross-linked. - [Engine](https://bioq.bio/engine.md): How the engine answers across all datasets: its layers, the guarantees on every answer and how one question reaches every layer. ## Access and pricing - [Pricing](https://bioq.bio/pricing.md): Try it free every month. When your team needs more, your company applies for a plan. ## Service and policies - [Status (JSON)](https://bioq.bio/api/v1/status): Live status of the engine and its layers (JSON, public, no key needed). - [Terms](https://bioq.bio/terms) - [Privacy](https://bioq.bio/privacy) ## BioQ Blog - [MDM2 vs MDM4: dependency and drugs side by side](https://bioq.bio/blog/en/compare-mdm2-vs-mdm4.md): MDM2 vs MDM4 in DepMap 24q4 Chronos data and drug annotations: 384 of 1178 cell lines depend on MDM2, 142 on MDM4; 12 drugs listed for MDM2, 1 for MDM4. (Data as of 2026-11-17) - [Tiratricol FDA approval: targets and potency in BioQ](https://bioq.bio/blog/en/tiratricol-fda-approval-2026-09-28.md): Tiratricol FDA approval (Emcitate): ChEMBL shows 68 targets, THRB and THRA top by pChEMBL, and 3 registered trials on ClinicalTrials.gov, as of 2026-11-17. (Data as of 2026-11-17) - [CD4 new study: CAR-NK cells and HIV rebound in context](https://bioq.bio/blog/en/cd4-nk-cells-engineered-with-a-chimeric-antigen-receptor-delay-hiv-rebound.md): A CD4-based CAR-NK paper on HIV rebound, placed in context with BioQ data on CD4: DepMap dependency, Open Targets diseases, drugs and Reactome pathways. (Data as of 2026-11-16) - [Zanzalintinib Anaplastic Thyroid Cancer Trial: NCT07470489](https://bioq.bio/blog/en/zanzalintinib-nct07470489-anaplastic-thyroid-cancer.md): Phase 2 trial NCT07470489 pairs zanzalintinib with cemiplimab in BRAF wild-type anaplastic thyroid cancer; ChEMBL, ClinicalTrials.gov and DepMap data inside. (Data as of 2026-11-16) - [GSTM1 new study: cisplatin kidney injury in context](https://bioq.bio/blog/en/gstm1-gstm1-deficiency-exacerbates-cisplatin-induced-kidney-injury-via-inc.md): A 2026 paper links GSTM1 loss to worse cisplatin kidney injury; BioQ shows what DepMap, Open Targets, ChEMBL, Reactome and STRING say about GSTM1 today. (Data as of 2026-11-16) - [Carboplatin Non-Small Cell Lung Cancer trial: NCT07877584](https://bioq.bio/blog/en/carboplatin-nct07877584-non-small-cell-lung-cancer.md): NCT07877584 is a phase 3 NSCLC trial of PD-1 blockade with or without chemotherapy; BioQ adds carboplatin ChEMBL potency and ClinicalTrials.gov context. (Data as of 2026-11-15) - [Semaglutide new study: what BioQ data show](https://bioq.bio/blog/en/semaglutide-semaglutide-and-panic-attacks-activecomparator-disproportional.md): A new FAERS paper on semaglutide and panic attacks, set against ChEMBL potency, ClinicalTrials.gov registrations and PubChem identity as of 2026-11-15. (Data as of 2026-11-15) - [Azacitidine Ropeginterferon trial NCT07646821](https://bioq.bio/blog/en/azacitidine-nct07646821-ropeginterferon.md): Phase 1b/2 trial NCT07646821 adds ropeginterferon alfa-2b to azacitidine in TP53-mutated MDS/AML; ChEMBL, ClinicalTrials.gov and DepMap data as of 2026-11-15. (Data as of 2026-11-15) - [JAK2 vs TYK2: dependency and drugs side by side](https://bioq.bio/blog/en/compare-jak2-vs-tyk2.md): JAK2 vs TYK2 in DepMap and drug databases: 8 of 1178 cell lines are dependent on JAK2, 11 on TYK2; 47 drugs are known for JAK2 and 20 for TYK2. (Data as of 2026-11-14) - [MYC new study: HCC microbiome paper and MYC data](https://bioq.bio/blog/en/myc-bacteroidetes-promote-hepatocellular-carcinoma-progression-and-resista.md): A paper watch on Bacteroidetes and HCC immunotherapy resistance, with what DepMap, Open Targets, TCGA, CIViC and STRING show about MYC as of 2026-11-14. (Data as of 2026-11-14) - [Docetaxel Non-Squamous Non-Small Cell Lung Cancer Trial](https://bioq.bio/blog/en/docetaxel-nct07821684-non-squamous-non-small-cell-lung-cancer.md): NCT07821684 is a phase 3 trial in non-squamous NSCLC; we pair it with docetaxel potency in ChEMBL, 1628 registered trials and EGFR dependency in DepMap. (Data as of 2026-11-14) - [TNKS2 new study: what BioQ data show today](https://bioq.bio/blog/en/tnks2-a-selective-tnks2-inhibitor-for-tumor-restricted-wnt-suppression.md): A Nature Chemical Biology paper on a TNKS2-selective inhibitor, set against DepMap, ChEMBL, Open Targets, Reactome and STRING data for TNKS2 as of 2026-11-13. (Data as of 2026-11-13) - [Zanubrutinib CLL trial NCT07899398 explained](https://bioq.bio/blog/en/zanubrutinib-nct07899398-cll-chronic-lymphocytic-leukemia.md): Trial watch on NCT07899398, a phase 2 zanubrutinib study in CLL, with ChEMBL potency and ClinicalTrials.gov counts for the drug as of 2026-11-13. (Data as of 2026-11-13) - [DYRK1A new study: what BioQ data show today](https://bioq.bio/blog/en/dyrk1a-dyrk1a-coordinates-tumorstroma-secretory-programs-that-promote-an-i.md): A new DYRK1A study in pancreatic cancer, set against DepMap dependency, ChEMBL compounds, Open Targets diseases and TCGA expression as of 2026-11-13. (Data as of 2026-11-13) - [Chlorhexidine Plaque-Induced Gingivitis trial NCT07905456](https://bioq.bio/blog/en/chlorhexidine-nct07905456-plaque-induced-gingivitis.md): NCT07905456 is a PHASE2 gingivitis trial starting 2026-12-01; we checked chlorhexidine in ChEMBL (104 targets) and ClinicalTrials.gov (101 studies). (Data as of 2026-11-12) - [All posts](https://bioq.bio/blog/en) · [Atom](https://bioq.bio/blog/en/feed.xml) ## Optional - [BioQ](https://bioq.bio/): Dozens of data layers once read one by one, now stacked and connected. Ask in plain words; the answer shows the evidence where the layers agree. - [한국어](https://bioq.bio/llms.txt?lang=ko): This index in 한국어. - [日本語](https://bioq.bio/llms.txt?lang=ja): This index in 日本語. - [简体中文](https://bioq.bio/llms.txt?lang=zh-CN): This index in 简体中文. - [繁體中文](https://bioq.bio/llms.txt?lang=zh-TW): This index in 繁體中文. - [Español](https://bioq.bio/llms.txt?lang=es): This index in Español. - [Français](https://bioq.bio/llms.txt?lang=fr): This index in Français. - [Deutsch](https://bioq.bio/llms.txt?lang=de): This index in Deutsch.